Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Lexagene Holdings Inc LXXGQ

Healthcare Medical Devices
Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in... see more

Recent & Breaking News (GREY:LXXGQ)

49 Public Companies to Present at the SNN Network Virtual Conference on August 3-6, 2020

Accesswire August 3, 2020

Testing's Critical Role in Stemming the Tide

GlobeNewswire July 22, 2020

LexaGene Hires First Direct Sales Executives and announces exercise of warrants

GlobeNewswire July 14, 2020

LexaGene Introduces its Commercial Product MiQLab(TM)

GlobeNewswire July 13, 2020

LexaGene to Host Webcast on July 14, 2020

GlobeNewswire July 8, 2020

LexaGene to Present at Lytham Partners Virtual Investor Growth Conference

GlobeNewswire June 22, 2020

LexaGene Provides Status Update on COVID-19 Testing at a Major Hospital Laboratory

GlobeNewswire June 18, 2020

LexaGene Holdings, Inc. Discusses the Sales Strategy for Its Pathogen Detection Technology with the Stock Day Podcast

Newsfile June 11, 2020

The Global Race for Testing and Vaccines for COVID-19 Sees Biotechnology Innovation at its Best

Newsfile June 3, 2020

LexaGene Provides Update on Commercializing its Automated Pathogen Detection System

GlobeNewswire June 1, 2020

LexaGene Places a Pre-Commercial Instrument for COVID-19 Testing in a Major Hospital Laboratory

GlobeNewswire May 28, 2020

LexaGene Holdings Receives Approval to Amend Warrant Terms

GlobeNewswire May 8, 2020

The Top Coronavirus-Related Small-Caps & Bullboards

Stockhouse Editorial April 27, 2020

LexaGene Holdings Proposes to Amend Warrants Terms and Announces a Strategic Marketing Promotional Campaign

GlobeNewswire April 23, 2020

LexaGene CEO Discusses COVID-19 Testing, Commercialization Strategy -- SECFilings.com

Newsfile April 16, 2020

LexaGene Files Patent Application for Expanded Capabilities of Their LX Analyzer

GlobeNewswire April 16, 2020

LexaGene Appoints Dr. Eleanor Kolossovski to Director of Product Marketing

GlobeNewswire April 1, 2020

LexaGene Appoints Steven Armstrong to Senior Director of Operations

GlobeNewswire March 24, 2020

LexaGene Provides Update on the Exercise of Warrants

GlobeNewswire March 17, 2020

LexaGene Provides Corporate Update

GlobeNewswire March 11, 2020